menu search

Adaptimmune: underappreciated biotech with bla filing q4 of 2022

SPEARHEAD-1 trial using afami-cel for the treatment of patients with synovial sarcoma and MRCLS met its...

June 29, 2022, 5:59 am

sarcos technology and robotics corporation (strc) ceo kiva allgood on q1 2022 results - earnings call transcript

sarcos Technology and Robotics Corporation (NASDAQ:STRC ) Q1 2022 Earnings Conference Call May 11, 2022...

May 11, 2022, 11:38 pm

Biophytis shares fall as it stops enrollment in sarconeos covid-19 trial, data expected in q3 2022

Biophytis SA (NASDAQ: BPTS) said that it is currently assessing FDA comments and recommendations and preparing to submit Phase 2-3 trial designs fo...

April 7, 2022, 8:15 am

sarcos technology and robotics corporation (strc) ceo kiva allgood on q4 2021 results - earnings call transcript

sarcos Technology and Robotics Corporation (STRC) CEO Kiva Allgood on Q4 2021 Results - Earnings Call T...

March 29, 2022, 8:07 pm

Epizyme (epzm) down more than 50% in past 3 months: here's why

Epizyme's (EPZM) lead drug, Tazverik, is approved to treat follicular lymphoma and epithelioid sarcoma ...

March 16, 2022, 1:32 pm

Sanofi (sny), blackstone ink deal for subcutaneous sarclisa

Sanofi (SNY) is developing a subcutaneous formulation of its myeloma drug, sarclisa. A pivotal study is...

March 16, 2022, 10:32 am

Tracon pharmaceuticals ends fy2021 with $24.1m in the bank; reveals key milestones for 2022

TRACON Pharmaceuticals (NASDAQ:TCON) Inc said it has ended its fiscal year 2021 with cash and equivalents of $24.1 million as of December 31, 2021, as...

March 15, 2022, 4:50 pm

Why are biophytis shares trading higher during premarket trading?

Biophytis SA BPTS has received approval from the ANVISA (Brazilian health authority) for its Expanded Access Program (EAP) to treat hospitalized pa...

February 3, 2022, 9:03 am

Why are biophytis shares trading higher during premarket trading?

Biophytis SA BPTS has received approval from the ANVISA (Brazilian health authority) for its Expanded Access Program (EAP) to treat hospitalized pa...

February 3, 2022, 9:03 am

Why are biophytis shares trading higher during premarket trading?

Biophytis SA BPTS has received approval from the ANVISA (Brazilian health authority) for its Expanded Access Program (EAP) to treat hospitalized pa...

February 3, 2022, 9:03 am

sarcos technology and robotics: a player in the fourth industrial revolution

sarcos Technology and Robotics: A Player In The Fourth Industrial Revolution...

February 3, 2022, 5:53 am

sarcos technology and robotics: a player in the fourth industrial revolution

sarcos Technology and Robotics: A Player In The Fourth Industrial Revolution...

February 3, 2022, 5:53 am

sarcos technology and robotics: a player in the fourth industrial revolution

sarcos Technology and Robotics: A Player In The Fourth Industrial Revolution...

February 3, 2022, 5:53 am

Veeva systems (veev)-lysarc partner to advance lymphoma therapy

Veeva Systems' (VEEV) Veeva Development Cloud will allow LYsarc to develop innovative lymphoma therapie...

January 25, 2022, 12:23 pm

Veeva systems (veev)-lysarc partner to advance lymphoma therapy

Veeva Systems' (VEEV) Veeva Development Cloud will allow LYsarc to develop innovative lymphoma therapie...

January 25, 2022, 12:23 pm

Veeva systems (veev)-lysarc partner to advance lymphoma therapy

Veeva Systems' (VEEV) Veeva Development Cloud will allow LYsarc to develop innovative lymphoma therapie...

January 25, 2022, 12:23 pm

Tracon pharmaceuticals and china-based eucure biopharma strike partnership to develop clinical-stage ctla-4 antibody yh001

TRACON Pharmaceuticals Inc. has entered into a collaborative partnership agreement with China-based Eucure Biopharma for the development of CTLA-4 ant...

October 11, 2021, 8:55 am

Tracon pharmaceuticals and china-based eucure biopharma strike partnership to develop clinical-stage ctla-4 antibody yh001

TRACON Pharmaceuticals Inc. has entered into a collaborative partnership agreement with China-based Eucure Biopharma for the development of CTLA-4 ant...

October 11, 2021, 8:55 am

Tracon pharmaceuticals and china-based eucure biopharma strike partnership to develop clinical-stage ctla-4 antibody yh001

TRACON Pharmaceuticals Inc. has entered into a collaborative partnership agreement with China-based Eucure Biopharma for the development of CTLA-4 ant...

October 11, 2021, 8:55 am


Search within

Pages Search Results: